Artificial Intelligence Models to Predict Recurrence in Patients with Differentiated Thyroid Cancer: A PROBAST + AI Systematic Review of Clinical Applicability.
BACKGROUND Differentiated thyroid cancer (DTC) generally carries an excellent prognosis, yet recurrence occurs in up to 8-9% of patients. Artificial intelligence (AI) models are increasingly proposed to predict DTC recurrence; however, their methodological quality and clinical readiness are poorly defined. We conducted...